T-type calcium channel blocker attenuates unilateral ureteral obstruction-induced renal interstitial fibrosis by activating the Nrf2 antioxidant pathway.
about
Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin.Role of glutathione biosynthesis in endothelial dysfunction and fibrosis.D‑Pinitol alleviates cyclosporine A‑induced renal tubulointerstitial fibrosis via activating Sirt1 and Nrf2 antioxidant pathways.
P2860
T-type calcium channel blocker attenuates unilateral ureteral obstruction-induced renal interstitial fibrosis by activating the Nrf2 antioxidant pathway.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
T-type calcium channel blocker ...... the Nrf2 antioxidant pathway.
@en
T-type calcium channel blocker ...... the Nrf2 antioxidant pathway.
@nl
type
label
T-type calcium channel blocker ...... the Nrf2 antioxidant pathway.
@en
T-type calcium channel blocker ...... the Nrf2 antioxidant pathway.
@nl
prefLabel
T-type calcium channel blocker ...... the Nrf2 antioxidant pathway.
@en
T-type calcium channel blocker ...... the Nrf2 antioxidant pathway.
@nl
P2093
P2860
P1476
T-type calcium channel blocker ...... the Nrf2 antioxidant pathway.
@en
P2093
Cheol Whee Park
Eun Sil Koh
Ho-Shik Kim
Hye Eun Yoon
Minyoung Kim
Seok Joon Shin
Soojeong Kim
Sungjin Chung
Yoon Sik Chang
P2860
P304
P407
P577
2016-11-15T00:00:00Z